Shitong Huang
Overview
Explore the profile of Shitong Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Yu Q, Zhang H, Liu Y, Wang H, Yang N, et al.
J Control Release
. 2025 Feb;
380:256-268.
PMID: 39894265
Tumor-specific T cells play a crucial role in tumor immunity. However, these cells are often scarce and functionally exhausted within the tumor microenvironment (TME), leading to the limited efficacy of...
2.
Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J, et al.
MedComm (2020)
. 2024 Oct;
5(11):e772.
PMID: 39465141
Cardiomyopathy is a group of disease characterized by structural and functional damage to the myocardium. The etiologies of cardiomyopathies are diverse, spanning from genetic mutations impacting fundamental myocardial functions to...
3.
Zhang W, Shi X, Huang S, Yu Q, Wu Z, Xie W, et al.
Cancer Immunol Immunother
. 2024 Oct;
73(12):245.
PMID: 39358493
Neoantigen vaccines represent an emerging and promising strategy in the field of tumor immunotherapy. Despite their potential, designing an effective neoantigen vaccine remains a challenge due to the current limitations...
4.
Yu Q, Zhang T, He T, Yang Y, Zhang W, Kang Y, et al.
Immunology
. 2024 Aug;
173(4):654-671.
PMID: 39174487
Personalized neoantigen therapy has shown long-term and stable efficacy in specific patient populations. However, not all patients have sufficient levels of neoantigens for treatment. Although somatic mutations are commonly found...
5.
Marsh J, Hacker L, Huang S, Boulet M, White J, Martin L, et al.
Dalton Trans
. 2024 Aug;
53(35):14811-14816.
PMID: 39169877
Hypoxia (low-oxygen) is one of the most common characteristics of solid tumours. Exploiting tumour hypoxia to reductively activate Pt(IV) prodrugs has the potential to deliver toxic Pt(II) selectively and thus...
6.
Duan S, Tian B, Huang G, Huang S, Zhou S
Curr Eye Res
. 2024 May;
49(9):905-913.
PMID: 38717185
Purpose: To establish and characterize a dry eye model in New Zealand rabbits by subcutaneous injections of scopolamine hydrobromide (SCOP). Methods: Twenty New Zealand male rabbits were injected subcutaneously SCOP...
7.
Huang S, Marsh J, White J, Ha T, Twigger S, Diez-Perez I, et al.
New J Chem
. 2024 May;
48(17):7548-7551.
PMID: 38689796
We report the synthesis of 4-nitrophenyl (4-NP) functionalised Pt(iv) complexes as a colorimetric strategy for monitoring Pt(iv) reduction in aqueous solution. Treatment of each 4-NP functionalised Pt(iv) complex with the...
8.
Huang S, Yang Y, Ouyang Z, Guo X, Zhan Z, Liu X, et al.
Eur J Dermatol
. 2022 Dec;
32(5):589-596.
PMID: 36468718
Background: The ocular features of phacomatosis pigmentovascularis (PPV) have rarely been reported, and glaucoma is the leading cause of blindness in patients with this condition. To protect vision in these...
9.
Han R, Su H, Guo G, Wang Q, Ma J, Li Z, et al.
Biomed Res Int
. 2021 Aug;
2021:9987931.
PMID: 34423043
Objective: Respiratory failure is the leading cause of mortality in COVID-19 patients, characterized by a generalized disbalance of inflammation. The aim of this study was to investigate the relationship between...
10.
Ni Y, Yang L, Han R, Guo G, Huang S, Weng L, et al.
Neuromodulation
. 2021 May;
24(6):983-991.
PMID: 34008282
Objectives: Implantable peripheral nerve stimulation has been increasingly used to treat neuropathic pain. This neuromodulation strategy may be an alternative option for intractable trigeminal neuropathic pain; however, evidence for this...